The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing personalized cancer immunotherapies.

Total Raised

$20 M

Rounds

1

Links

Verticals

Biotechnology
Chemical
Oncology

Investment History

  1. Series A

    Dec 2025

    $20M

Team

Michael Hudecek

Co-Founder

Dr. Caroline Burger

Global Head of Business Development

Karl Schumacher

Chief Clinical Officer